One of the most debilitating side effects many breast cancer survivors experience is cognitive impairment, often referred to as “chemobrain” and attributed to the mental fogginess from chemotherapy. It’s time for all of us — especially employers and health care providers — to acknowledge that cognitive impairment is as real and potentially devastating as any other symptom or side effect. And it’s time for supervisors to make reasonable accommodations, as mandated by federal legislation.Read more
LIVESTRONG Foundation Gift to Dell Medical School Allows UT Austin to Surpass $3 Billion Campaign Goal
With a $50 million gift from the LIVESTRONG Foundation to the Dell Medical School, The University of Texas at Austin has exceeded its goal of raising $3 billion during the eight-year Campaign for Texas.Read more
The $50 million gift will establish the LIVESTRONG Cancer Institutes at the Dell Medical School. Read more about how the partnership will advance a new model of patient-centered care.Read more
Researchers have determined that postmenopausal overweight or obese breast cancer patients receiving hormone therapy as part of their treatment and who use nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen have significantly lower breast cancer recurrence rates and a sizable delay in time to cancer recurrence.Read more
AUSTIN, Texas Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells.
These synthetic ion transporters, described this week in the journal Nature Chemistry, confirm a two-decades-old hypothesis that could point the way to new anticancer drugs while also benefiting patients with cystic fibrosis.Read more